LivingMed Biotech SRL
LivingMed Biotech reported total assets of 51,717 € at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Jul 2026).
The score of LivingMed Biotech shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
LivingMed Biotech's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jul 2026
- Year ended 31 Dec 2024filed on 28 Jul 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
- Year ended 31 Dec 2022filed on 26 Jul 2023
- Year ended 31 Dec 2021filed on 05 Jul 2022
LivingMed Biotech's financial analysis
- Solvency-599.2%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of LivingMed Biotech
LivingMed Biotech's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0748.443.684
- VAT number
- BE0748443684
- Peppol
- Registered · 0208:0748443684 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Jun 2020
- Registered office
- 6900 Marche-en-Famenne
- Latest accounts
- 2025 · filed on 08 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
LivingMed Biotech (SRL) has been based in Marche-en-Famenne since 2020, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 200,048 € and equity of −309,865 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to LivingMed Biotech
Companies in the same business, of comparable size and area, outside its group.
- NanoBiotech Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 1,834 €
- NCD Consultants Research and experimental development on natural sciences and engineering Overijse · balance sheet 55,512 €
- Sealantium Medical Belgium Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 56,033 €
- Docteur Freddy Vantomme Research and experimental development on natural sciences and engineering Mouscron · balance sheet 60,491 €
- Bridging for Sustainability Research and experimental development on natural sciences and engineering Clavier · balance sheet 44,057 €
- Eurimmaux Research and experimental development on natural sciences and engineering Jette · balance sheet 43,305 €
- BMRF Consult Research and experimental development on natural sciences and engineering Trooz · balance sheet 63,686 €
- GDP Health Research and experimental development on natural sciences and engineering Lasne · balance sheet 70,909 €
Frequently asked questions about LivingMed Biotech
What is the revenue of LivingMed Biotech?
LivingMed Biotech files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of LivingMed Biotech?
In Belgium, the VAT number is the company number prefixed with BE: BE0748443684 for LivingMed Biotech, if the company is VAT-registered. Its company number (CBE) is 0748.443.684.
Where is the registered office of LivingMed Biotech?
According to the CBE register, the registered office of LivingMed Biotech is in 6900 Marche-en-Famenne.
What is the equity of LivingMed Biotech?
At the close of the 2025 financial year, the equity of LivingMed Biotech amounts to -309,865 €, a solvency of -599.2% of total assets.
Who manages LivingMed Biotech?
The register lists 2 active mandates at LivingMed Biotech. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of LivingMed Biotech
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →